[ad_1]
U.S. airlines have struggled with weakness in the domestic market, facing a mismatch between capacity and demand that is casting a shadow over the second half of the year.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...